Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Related structures:
AlphaFold database: Q4QBX1
Term | Name | Level | Count |
---|---|---|---|
GO:0006793 | phosphorus metabolic process | 3 | 10 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 10 |
GO:0008152 | metabolic process | 1 | 10 |
GO:0009987 | cellular process | 1 | 10 |
GO:0016311 | dephosphorylation | 5 | 10 |
GO:0044237 | cellular metabolic process | 2 | 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 10 |
GO:0004721 | phosphoprotein phosphatase activity | 3 | 10 |
GO:0016787 | hydrolase activity | 2 | 10 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 10 |
GO:0016791 | phosphatase activity | 5 | 10 |
GO:0042577 | lipid phosphatase activity | 6 | 2 |
GO:0042578 | phosphoric ester hydrolase activity | 4 | 10 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 10 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 113 | 115 | PF00675 | 0.342 |
CLV_PCSK_KEX2_1 | 113 | 115 | PF00082 | 0.330 |
CLV_PCSK_KEX2_1 | 223 | 225 | PF00082 | 0.315 |
CLV_PCSK_KEX2_1 | 5 | 7 | PF00082 | 0.532 |
CLV_PCSK_PC1ET2_1 | 223 | 225 | PF00082 | 0.315 |
CLV_PCSK_PC1ET2_1 | 5 | 7 | PF00082 | 0.491 |
CLV_PCSK_SKI1_1 | 114 | 118 | PF00082 | 0.294 |
CLV_PCSK_SKI1_1 | 128 | 132 | PF00082 | 0.327 |
CLV_PCSK_SKI1_1 | 136 | 140 | PF00082 | 0.342 |
CLV_PCSK_SKI1_1 | 50 | 54 | PF00082 | 0.385 |
DEG_SPOP_SBC_1 | 253 | 257 | PF00917 | 0.469 |
DOC_MAPK_gen_1 | 136 | 145 | PF00069 | 0.315 |
DOC_MAPK_gen_1 | 56 | 65 | PF00069 | 0.287 |
DOC_MAPK_MEF2A_6 | 200 | 207 | PF00069 | 0.385 |
DOC_PP2B_LxvP_1 | 165 | 168 | PF13499 | 0.330 |
DOC_PP2B_LxvP_1 | 84 | 87 | PF13499 | 0.231 |
DOC_USP7_MATH_1 | 253 | 257 | PF00917 | 0.444 |
DOC_USP7_UBL2_3 | 124 | 128 | PF12436 | 0.417 |
DOC_USP7_UBL2_3 | 28 | 32 | PF12436 | 0.337 |
DOC_USP7_UBL2_3 | 56 | 60 | PF12436 | 0.385 |
DOC_WW_Pin1_4 | 43 | 48 | PF00397 | 0.385 |
DOC_WW_Pin1_4 | 71 | 76 | PF00397 | 0.347 |
LIG_14-3-3_CanoR_1 | 113 | 123 | PF00244 | 0.352 |
LIG_AP2alpha_1 | 130 | 134 | PF02296 | 0.305 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.414 |
LIG_FHA_1 | 115 | 121 | PF00498 | 0.392 |
LIG_FHA_1 | 188 | 194 | PF00498 | 0.333 |
LIG_FHA_1 | 88 | 94 | PF00498 | 0.366 |
LIG_FHA_2 | 161 | 167 | PF00498 | 0.329 |
LIG_FHA_2 | 169 | 175 | PF00498 | 0.306 |
LIG_LIR_Apic_2 | 248 | 253 | PF02991 | 0.287 |
LIG_LIR_Gen_1 | 129 | 138 | PF02991 | 0.203 |
LIG_LIR_Nem_3 | 122 | 126 | PF02991 | 0.337 |
LIG_LIR_Nem_3 | 129 | 134 | PF02991 | 0.316 |
LIG_LIR_Nem_3 | 215 | 221 | PF02991 | 0.340 |
LIG_LIR_Nem_3 | 82 | 86 | PF02991 | 0.428 |
LIG_Pex14_2 | 119 | 123 | PF04695 | 0.357 |
LIG_Pex14_2 | 130 | 134 | PF04695 | 0.289 |
LIG_SH2_CRK | 225 | 229 | PF00017 | 0.315 |
LIG_SH2_PTP2 | 250 | 253 | PF00017 | 0.354 |
LIG_SH2_SRC | 83 | 86 | PF00017 | 0.345 |
LIG_SH2_STAT5 | 250 | 253 | PF00017 | 0.453 |
LIG_SH2_STAT5 | 61 | 64 | PF00017 | 0.385 |
LIG_SH2_STAT5 | 83 | 86 | PF00017 | 0.364 |
LIG_Sin3_3 | 157 | 164 | PF02671 | 0.385 |
LIG_SUMO_SIM_anti_2 | 201 | 207 | PF11976 | 0.203 |
LIG_TYR_ITIM | 31 | 36 | PF00017 | 0.385 |
LIG_TYR_ITIM | 81 | 86 | PF00017 | 0.373 |
LIG_UBA3_1 | 53 | 60 | PF00899 | 0.385 |
LIG_WRC_WIRS_1 | 127 | 132 | PF05994 | 0.203 |
MOD_CDK_SPxxK_3 | 43 | 50 | PF00069 | 0.385 |
MOD_CK1_1 | 187 | 193 | PF00069 | 0.389 |
MOD_CK2_1 | 168 | 174 | PF00069 | 0.387 |
MOD_Cter_Amidation | 48 | 51 | PF01082 | 0.385 |
MOD_GlcNHglycan | 106 | 109 | PF01048 | 0.315 |
MOD_GSK3_1 | 251 | 258 | PF00069 | 0.463 |
MOD_GSK3_1 | 87 | 94 | PF00069 | 0.366 |
MOD_N-GLC_2 | 180 | 182 | PF02516 | 0.337 |
MOD_NEK2_1 | 145 | 150 | PF00069 | 0.288 |
MOD_NEK2_1 | 160 | 165 | PF00069 | 0.281 |
MOD_NEK2_1 | 176 | 181 | PF00069 | 0.310 |
MOD_NEK2_2 | 87 | 92 | PF00069 | 0.315 |
MOD_OFUCOSY | 182 | 188 | PF10250 | 0.385 |
MOD_PK_1 | 224 | 230 | PF00069 | 0.315 |
MOD_PKA_2 | 251 | 257 | PF00069 | 0.446 |
MOD_Plk_4 | 115 | 121 | PF00069 | 0.335 |
MOD_Plk_4 | 126 | 132 | PF00069 | 0.271 |
MOD_Plk_4 | 168 | 174 | PF00069 | 0.284 |
MOD_Plk_4 | 79 | 85 | PF00069 | 0.433 |
MOD_ProDKin_1 | 43 | 49 | PF00069 | 0.385 |
MOD_ProDKin_1 | 71 | 77 | PF00069 | 0.347 |
MOD_SUMO_rev_2 | 44 | 52 | PF00179 | 0.377 |
MOD_SUMO_rev_2 | 64 | 72 | PF00179 | 0.315 |
TRG_ENDOCYTIC_2 | 127 | 130 | PF00928 | 0.339 |
TRG_ENDOCYTIC_2 | 225 | 228 | PF00928 | 0.295 |
TRG_ENDOCYTIC_2 | 33 | 36 | PF00928 | 0.463 |
TRG_ENDOCYTIC_2 | 83 | 86 | PF00928 | 0.416 |
TRG_ER_diArg_1 | 112 | 114 | PF00400 | 0.339 |
TRG_ER_diArg_1 | 22 | 25 | PF00400 | 0.382 |
TRG_NES_CRM1_1 | 109 | 125 | PF08389 | 0.385 |
TRG_Pf-PMV_PEXEL_1 | 51 | 55 | PF00026 | 0.406 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P4V5 | Leptomonas seymouri | 63% | 100% |
A0A0N1HYX0 | Leptomonas seymouri | 31% | 100% |
A0A0N1PC37 | Leptomonas seymouri | 33% | 100% |
A0A0N1PFC3 | Leptomonas seymouri | 37% | 100% |
A0A3S7WWX6 | Leishmania donovani | 93% | 100% |
A0A3S7X743 | Leishmania donovani | 26% | 100% |
A4HZQ2 | Leishmania infantum | 93% | 100% |
A4I9C5 | Leishmania infantum | 26% | 100% |
E9AVK8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 100% |
E9B4C5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 27% | 100% |
I6WXK4 | Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) | 22% | 93% |
P40289 | Cupriavidus necator (strain ATCC 17699 / DSM 428 / KCTC 22496 / NCIMB 10442 / H16 / Stanier 337) | 28% | 95% |
Q4Q3Q1 | Leishmania major | 28% | 100% |